Seth H. Blum

906 citations

23 papers · 546 indexed · h-index 14

Cellular and Molecular Neuroscience top 10%
Psychiatry and Mental health top 5%
Pharmacology top 10%
Physiology
Cognitive Neuroscience top 10%

Co-authors: Thomas J.H. Chen Kenneth Blum Eric R. Braverman Bernard W. Downs Roger L. Waite Vanessa Arcuri Mallory Kerner Tomás Palomo
Topics: Pharmacology and Obesity Treatment (6 papers)Neurotransmitter Receptor Influence on Behavior (6 papers)Attention Deficit Hyperactivity Disorder (4 papers)
Cited by: Psychiatry and Mental health Cellular and Molecular Neuroscience Endocrine and Autonomic Systems
Journals: Advances in Therapy Journal of Psychoactive Drugs Medical Hypotheses
Partner nations: United States Taiwan Spain

In The Last Decade

Seth H. Blum

23 papers receiving 512 citations

Peers

Countries citing papers authored by Seth H. Blum

Since Specialization

Citations

This map shows the geographic impact of Seth H. Blum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Seth H. Blum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Seth H. Blum more than expected).

Fields of papers citing papers by Seth H. Blum

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Seth H. Blum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Seth H. Blum. The network helps show where Seth H. Blum may publish in the future.

Co-authorship network of co-authors of Seth H. Blum

This figure shows the co-authorship network connecting the top 25 collaborators of Seth H. Blum. A scholar is included among the top collaborators of Seth H. Blum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Seth H. Blum. Seth H. Blum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hypothesizing “Reward” Gene Polymorphisms May Predict High Rates of Injury and Addiction in the Workforce: A Nutrient and Electrotherapeutic Based Solution 2014 ·Health ·Kenneth Blum,(unknown),Roger L. Waite,Seth H. Blum,Kristina Dushaj,Margaret Madigan,Eric R. Braverman,(unknown)	1
2	Healing enhancement of chronic venous stasis ulcers utilizing H-WAVE®device therapy: a case series 2010 ·Cases Journal ·Kenneth Blum,(unknown),(unknown),Bernard W. Downs,Eric R. Braverman,Mallory Kerner,(unknown),(unknown),Margaret Madigan,Seth H. Blum,(unknown),John Giordano,Nicholas A. DiNubile	5
3	Nutrigenomic targeting of carbohydrate craving behavior: Can we manage obesity and aberrant craving behaviors with neurochemical pathway manipulation by Immunological Compatible Substances (nutrients) using a Genetic Positioning System (GPS) Map? 2009 ·Medical Hypotheses ·Bernard W. Downs,Amanda LC Chen,Thomas J.H. Chen,Roger L. Waite,Eric R. Braverman,Mallory Kerner,(unknown),Patrick Rhoades,Thomas J. Prihoda,Tomás Palomo,Marlene Oscar‐Berman,Jeffrey Reinking,Seth H. Blum,Nicholas A. DiNubile,(unknown),Kenneth Blum	21
4	Putative targeting of Dopamine D2 receptor function in Reward Deficiency Syndrome (RDS) by Synaptamine Complex™ Variant (KB220): Clinical trial showing anti-anxiety effects 2009 ·Kenneth Blum,(unknown),(unknown),Abdalla Bowirrat,Roger L. Waite,Mallory Kerner,Seth H. Blum,Bernard W. Downs,Patrick Rhoades,Jeffrey Reinking,Eric R. Braverman,Nicholas A. DiNubile	15
5	LG839: Anti-obesity effects and polymorphic gene correlates of reward deficiency syndrome 2008 ·Advances in Therapy ·Kenneth Blum,Amanda LC Chen,Thomas J.H. Chen,Patrick Rhoades,Thomas J. Prihoda,Bernard W. Downs,Roger L. Waite,(unknown),Eric R. Braverman,(unknown),Vanessa Arcuri,Mallory Kerner,Seth H. Blum,Tomás Palomo	41
6	Activation instead of blocking mesolimbic dopaminergic reward circuitry is a preferred modality in the long term treatment of reward deficiency syndrome (RDS): a commentary 2008 ·Theoretical Biology and Medical Modelling ·Kenneth Blum,(unknown),Thomas J.H. Chen,Eric R. Braverman,Jeffrey Reinking,Seth H. Blum,(unknown),Bernard W. Downs,Roger L. Waite,(unknown),Thomas J. Prihoda,Mallory Kerner,Tomás Palomo,David E. Comings,Howard Tung,Patrick Rhoades,Marlene Oscar‐Berman	112
7	Hypothesizing that brain reward circuitry genes are genetic antecedents of pain sensitivity and critical diagnostic and pharmacogenomic treatment targets for chronic pain conditions 2008 ·Medical Hypotheses ·Amanda LC Chen,Thomas J.H. Chen,Roger L. Waite,Jeffrey Reinking,Howard Tung,Patrick Rhoades,Bernard W. Downs,Eric R. Braverman,(unknown),Mallory Kerner,Seth H. Blum,Nicholas A. DiNubile,David E. Smith,Marlene Oscar‐Berman,Thomas J. Prihoda,(unknown),David O’Brien,(unknown),Kenneth Blum	36
8	Hypothesizing that Marijuana Smokers are at a Significantly Lower Risk of Carcinogenicity Relative to Tobacco-Non-Marijuana Smokers: Evidenced Based on Statistical Reevaluation of Current Literature 2008 ·Journal of Psychoactive Drugs ·Amanda LC Chen,Thomas J.H. Chen,Eric R. Braverman,(unknown),Mallory Kerner,(unknown),(unknown),William B. Downs,Seth H. Blum,(unknown),Kenneth Blum	9
9	A short term pilot open label study to evaluate efficacy and safety of LG839, a customized DNA directed nutraceutical in obesity: Exploring Nutrigenomics 2008 ·Kenneth Blum,Thomas J.H. Chen,(unknown),(unknown),William B. Downs,Roger L. Waite,(unknown),Simon H. Sims,Thomas J. Prihoda,(unknown),Jeffrey Reinking,(unknown),Mallory Kerner,Seth H. Blum,(unknown),Eric R. Braverman	23
10	Dopamine D2 receptor Taq A1 allele predicts treatment compliance of LG839 in a subset analysis of pilot study in the Netherlands 2008 ·Kenneth Blum,Thomas J.H. Chen,Amanda LC Chen,Patrick Rhoades,Thomas J. Prihoda,Bernard W. Downs,Debasis Bagchi,Manashi Bagchi,Seth H. Blum,(unknown),Eric R. Braverman,Mallory Kerner,Roger L. Waite,(unknown),Lisa D. White,Jeffrey Reinking	33
11	Gene Narcotic Attenuation Program attenuates substance use disorder, a clinical subtype of reward deficiency syndrome 2007 ·Advances in Therapy ·Thomas J.H. Chen,Kenneth Blum,Roger L. Waite,(unknown),John Schoolfield,(unknown),(unknown),Vanessa Arcuri,(unknown),Seth H. Blum,(unknown),(unknown),Tomás Palomo	25
12	Plasma growth hormones, P300 event-related potential and test of variables of attention (TOVA) are important neuroendocrinological predictors of early cognitive decline in a clinical setting: Evidence supported by structural equation modeling (SEM) parameter estimates 2007 ·AGE ·Eric R. Braverman,Thomas J.H. Chen,Thomas J. Prihoda,William E. Sonntag,(unknown),Bernard W. Downs,(unknown),Seth H. Blum,(unknown),Vanessa Arcuri,(unknown),Kenneth Blum	7
13	Manipulation of catechol-O-methyl-transferase (COMT) activity to influence the attenuation of substance seeking behavior, a subtype of Reward Deficiency Syndrome (RDS), is dependent upon gene polymorphisms: A hypothesis 2007 ·Medical Hypotheses ·Kenneth Blum,Thomas J.H. Chen,(unknown),Roger L. Waite,Bernard W. Downs,Seth H. Blum,(unknown),Vanessa Arcuri,Eric R. Braverman,Tomás Palomo	42
14	Genotrim™, a DNA-customized nutrigenomic product, targets genetic factors of obesity: Hypothesizing a dopamine–glucose correlation demonstrating reward deficiency syndrome (RDS) 2006 ·Medical Hypotheses ·Kenneth Blum,Thomas J.H. Chen,(unknown),Bernard W. Downs,(unknown),Seth H. Blum,(unknown),Eric R. Braverman,Vanessa Arcuri,(unknown),Manuel Martínez Pons	31
15	Delayed P300 latency correlates with abnormal Test of Variables of Attention (TOVA) in adults and predicts early cognitive decline in a clinical setting 2006 ·Advances in Therapy ·Eric R. Braverman,Thomas J.H. Chen,John Schoolfield,Manuel Martinez-Pons,Vanessa Arcuri,(unknown),(unknown),(unknown),Seth H. Blum,(unknown),Bernard W. Downs,Kenneth Blum	18
16	Reward deficiency syndrome in obesity: A preliminary cross-sectional trial with a genotrim variant 2006 ·Advances in Therapy ·Kenneth Blum,Thomas J.H. Chen,(unknown),Bernard W. Downs,(unknown),Seth H. Blum,(unknown),Eric R. Braverman,Vanessa Arcuri,(unknown),(unknown),Manuel Martinez-Pons	44
17	H-wave®, a nonpharmacologic alternative for the treatment of patients with chronic soft tissue inflammation and neuropathic pain: A preliminary statistical outcome study 2006 ·Advances in Therapy ·Kenneth Blum,Nicholas A. DiNubile,Thomas J.H. Chen,Roger L. Waite,John Schoolfield,Manuel Martinez-Pons,Michael F. Callahan,Thomas L. Smith,(unknown),Seth H. Blum,(unknown)	12
18	The H-Wave® small muscle fiber stimulator, a nonpharmacologic alternative for the treatment of chronic soft-tissue injury and neuropathic pain: an extended population observational study 2006 ·Advances in Therapy ·Kenneth Blum,Thomas J.H. Chen,Manuel Martínez Pons,Nicholas A. DiNubile,Roger L. Waite,John Schoolfield,Seth H. Blum,(unknown),Bernard W. Downs,(unknown)	10
19	Nutrigenomics and pharmacogenomics: a scientific wonderland 2006 ·Social Science Information ·Kenneth Blum,Thomas J.H. Chen,Seth H. Blum,Bernard W. Downs,Eric R. Braverman,(unknown),(unknown)	4
20	Neurogenetic interactions and aberrant behavioral co-morbidity of attention deficit hyperactivity disorder (ADHD): dispelling myths 2005 ·Theoretical Biology and Medical Modelling ·David E. Comings,Thomas J.H. Chen,Kenneth Blum,(unknown),Seth H. Blum,(unknown)	22

About Seth H. Blum

Seth H. Blum is a scholar working on Pharmacology, Psychiatry and Mental health and Physiology, having authored 23 papers that have together received 546 indexed citations. Recurring topics across this work include Pharmacology and Obesity Treatment (6 papers), Neurotransmitter Receptor Influence on Behavior (6 papers) and Attention Deficit Hyperactivity Disorder (4 papers). The work is most often cited by research in Psychiatry and Mental health (214 citations), Cellular and Molecular Neuroscience (247 citations) and Endocrine and Autonomic Systems (51 citations). Seth H. Blum has collaborated with scholars based in United States, Taiwan and Spain. Frequent co-authors include Thomas J.H. Chen, Kenneth Blum, Eric R. Braverman, Bernard W. Downs, Roger L. Waite, Vanessa Arcuri, Mallory Kerner, Tomás Palomo, Thomas J. Prihoda and Patrick Rhoades. Their work appears in journals such as Advances in Therapy, Journal of Psychoactive Drugs and Medical Hypotheses.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact